risks of microdosing glp 1 GLP-1s: Does It Work? and Benefits Microdosing GLP-1 | AgelessRx

-SMA: alpha smooth muscle actin

Yri HM, Fagerlund B, Forchhammer HB, Jensen RH

If you try one, dont expect to see more than just a shadow of the weight loss (at best) that people experience from a GLP-1 drug

Keywords: glucagon-like peptide-1 receptor agonist, health technology assessment, type 2 diabetes mellitus, drug evaluation Introduction Hospital-based health technology assessment (HB-HTA) refers to the comprehensive and systematic evaluation of relevant health technologies based on the actual needs of hospitals, using the principles and methods of evidence-based medicine and health technology assessment to make rapid decisions about the selection, acquisition, and use of new technologies to improve health equity and is a commonly used policy analysis tool internationally

For diabetic patients, weigh glycemic control needs against surgical risks and consult endocrinology if preoperative insulin changes were significant